Long intergenic non-coding RNA 00337 confers progression of esophageal cancer by mediating microrna-145-dependent fscn1

被引:7
|
作者
Shi, Lixia [1 ]
Chen, Qing [1 ]
Ge, Xiaofen [2 ]
机构
[1] Linyi Peoples Hosp, Dept Gen Surg, Linyi, Shandong, Peoples R China
[2] Linyi Peoples Hosp, Infect Dis Clin, 27 East Sect Jiefang Rd, Linyi 276000, Shandong, Peoples R China
关键词
esophageal cancer; FSCN1; invasion; long intergenic non-coding RNA; microRNA-145; migration; proliferation; SQUAMOUS-CELL CARCINOMA; EXPRESSION; PROLIFERATION; MIR-145; INVASION; ASSOCIATION; METASTASIS; MIGRATION; EPIDEMIOLOGY; HOTAIR;
D O I
10.1096/fj.202000470
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long non-coding RNAs (lncRNAs) have been highlighted as prominent genetic modulators involved in multiple important biological processes of cancer cells, especially in esophageal cancer (EC). We tried to elucidate the potential role of LINC00337 in the progression of EC. Based on TCGA database analysis and Reverse transcription quantitative polymerase chain reaction determination, high expression of LINC00337 and FSCN1 was detected, while miR-145 exhibited a low expression in EC. LINC00337 was identified to bind to miR-145 to impair the miR-145-dependent FSCN1 inhibition. The underlying regulatory mechanisms were evaluated by transfection with LINC00337 overexpression plasmid, siRNA against LINC00337, miR-145 mimic, or anta-miR-145. Downregulation of LINC00337 results in increased Bax level, decreased FSCN1, Bcl-2, VEGF, and p53 levels, in addition to diminished cell proliferation, migration, invasion and tumor growth, with accelerated cell apoptosis by upregulating miR-145. Taken together, the findings obtained provided evidence suggesting that LINC00337 acts as a tumor promoter in EC, providing insight and advancements for EC treatment.
引用
收藏
页码:11431 / 11443
页数:13
相关论文
共 50 条
  • [1] Biological role of long non-coding RNA FTX in cancer progression
    Yang, Jinlan
    Qu, Tianyin
    Li, Yajun
    Ma, Jingjing
    Yu, Huangfei
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [2] Clinical Application of Long Non-Coding RNA-UCA1 as a Candidate Gene in Progression of Esophageal Cancer
    Aalijahan, Hamid
    Ghorbian, Saeid
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1441 - 1446
  • [3] Long non-coding RNA SNHG3 promotes prostate cancer progression by sponging microRNA-1827
    Hu, Ming
    Ren, Mingliang
    Zhao, Zhenhua
    Cui, Xuejiang
    Shi, Ming
    Yang, Yunjie
    Guo, Haiyan
    ONCOLOGY LETTERS, 2022, 24 (02)
  • [4] HOXD-AS1: a novel oncogenic long intergenic non-coding RNA in humans
    Xie, S. C.
    Yang, Y. J.
    Zhang, J. Q.
    Zhou, S.
    Xie, S. W.
    Hua, Y. Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (07) : 2898 - 2907
  • [5] Involvement of long non-coding RNAs in the progression of esophageal cancer
    Xue, Wenhua
    Zheng, Yuanyuan
    Shen, Zhibo
    Li, Lifeng
    Fan, Zhirui
    Wang, Wenbin
    Zhu, Zijia
    Zhai, Yunkai
    Zhao, Jie
    Kan, Quancheng
    CANCER COMMUNICATIONS, 2021, 41 (05) : 371 - 388
  • [6] Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer
    Xu, Weibo
    Chang, Junkai
    Du, Xinyi
    Hou, Junqing
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 1112 - 1118
  • [7] Long Non-Coding RNA lincRNA-ROR Promotes the Progression of Colon Cancer and Holds Prognostic Value by Associating with miR-145
    Zhou, Peng
    Sun, Lixia
    Liu, Danfeng
    Liu, Changkuo
    Sun, Lei
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (04) : 733 - 740
  • [8] Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression
    Jiang, Rong
    Zhang, Hongyu
    Zhou, Jinhua
    Wang, Juan
    Xu, Yuejuan
    Zhang, He
    Gu, Yanzheng
    Fu, Fengqing
    Shen, Yu
    Zhang, Guangbo
    Feng, Lanlan
    Zhang, Xueguang
    Chen, Youguo
    Shen, Fangrong
    CELL DEATH & DISEASE, 2021, 12 (02)
  • [9] DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA
    Hu, Chengyu
    Liu, Kai
    Wang, Bei
    Xu, Wen
    Ling, Yexiang
    Yuan, Chengfu
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (09) : 1211 - 1218
  • [10] The role of long non-coding RNA FGD5-AS1 in cancer
    He, Na
    Xiang, Linbiao
    Chen, Lei
    Tong, Haobin
    Wang, Keshen
    Zhao, Jie
    Song, Feixue
    Yang, Hanteng
    Wei, Xinyuan
    Jiao, Zuoyi
    BIOENGINEERED, 2022, 13 (04) : 11026 - 11041